NO953578L - Injiserbare liposomale legemiddeltilberedninger - Google Patents

Injiserbare liposomale legemiddeltilberedninger

Info

Publication number: NO953578L
Authority: NO; Norway
Prior art keywords: phospholipid; liposomal drug; drug preparations; injectable liposomal; injectable
Prior art date: 1994-09-12

Application number

NO953578A

Other languages

English (en)

Other versions

NO953578D0 (no

NO311556B1 (no

Inventor

Hans-Jurgen Hamann

Peter Serno

Matthias Herboth

Peter Kurka

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-12

Filing date

1995-09-11

Publication date

1996-03-13

1995-09-11 Application filed by Bayer Ag filed Critical Bayer Ag

1995-09-11 Publication of NO953578D0 publication Critical patent/NO953578D0/no

1996-03-13 Publication of NO953578L publication Critical patent/NO953578L/no

2001-12-10 Publication of NO311556B1 publication Critical patent/NO311556B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
External Artificial Organs (AREA)
Glass Compositions (AREA)

NO19953578A 1994-09-12 1995-09-11 Injiserbare liposomale legemiddeltilberedninger, samt anvendelse av den deri tilstedev¶rende, kortkjedede fettsyre NO311556B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4432378A DE4432378A1 (de)	1994-09-12	1994-09-12	Injizierbare liposomale Arzneizubereitungen

Publications (3)

Publication Number	Publication Date
NO953578D0 NO953578D0 (no)	1995-09-11
NO953578L true NO953578L (no)	1996-03-13
NO311556B1 NO311556B1 (no)	2001-12-10

Family

ID=6527981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19953578A NO311556B1 (no)	1994-09-12	1995-09-11	Injiserbare liposomale legemiddeltilberedninger, samt anvendelse av den deri tilstedev¶rende, kortkjedede fettsyre

Country Status (28)

Country	Link
US (1)	US5653998A (no)
EP (1)	EP0700679B1 (no)
JP (1)	JPH0881361A (no)
KR (1)	KR960009998A (no)
CN (1)	CN1079668C (no)
AT (1)	ATE187327T1 (no)
AU (1)	AU698441B2 (no)
CA (1)	CA2157849A1 (no)
CZ (1)	CZ287975B6 (no)
DE (2)	DE4432378A1 (no)
DK (1)	DK0700679T3 (no)
EE (1)	EE03377B1 (no)
ES (1)	ES2139800T3 (no)
FI (1)	FI954204A7 (no)
GR (1)	GR3032664T3 (no)
HU (1)	HUT73808A (no)
IL (1)	IL115222A (no)
MY (1)	MY111841A (no)
NO (1)	NO311556B1 (no)
NZ (1)	NZ272943A (no)
PL (1)	PL181541B1 (no)
PT (1)	PT700679E (no)
RU (1)	RU2160099C2 (no)
SI (1)	SI0700679T1 (no)
SK (1)	SK281611B6 (no)
TW (1)	TW359616B (no)
UA (1)	UA29469C2 (no)
ZA (1)	ZA957604B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
DE19709704C2 (de)	1997-03-10	1999-11-04	Michael Georgieff	Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US7030155B2 (en)	1998-06-05	2006-04-18	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
KR20000003433A (ko) *	1998-06-29	2000-01-15	김영환	반도체소자의 커패시터 제조방법
EP1146959B1 (en) *	1998-11-13	2008-06-04	William A. Heriot	Apparatus for liposome production
EP1183011A4 (en) *	1999-05-14	2005-01-19	Esperion Luv Dev Inc	METHOD FOR THE TREATMENT OF ANGINA AND / OR SIMILAR ILLNESSES AND THE MEDICINAL PRODUCTS AND KITS THEREOF
EP1259225B1 (en)	2000-02-04	2006-10-04	Lipoxen Technologies Limited	Process of dehydration/rehydration for making liposomes
US20060177416A1 (en)	2003-10-14	2006-08-10	Medivas, Llc	Polymer particle delivery compositions and methods of use
DK2286795T3 (en)	2002-06-26	2017-02-06	Syncore Biotechnology Co Ltd	PROCEDURE FOR PREPARING A Cationic LIPOSOMAL PREPARATION INCLUDING A LIPOPHIL COMPOUND
DE10255195A1 (de) *	2002-11-27	2004-06-09	Lipoid Gmbh	Micellare wasserlösliche Konzentrate
WO2005002546A1 (en) *	2003-06-27	2005-01-13	Smithkline Beecham Corporation	Stabilized topotecan liposomal composition and methods
US7345093B2 (en) *	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
US20080095834A1 (en) *	2005-03-02	2008-04-24	Volkmar Weissig	Mitochondriotropic Phospholipid Vesicles
MX2007015577A (es) *	2005-06-09	2008-02-25	Biolipox Ab	Metodo y composiciones para el tratamiento de trastornos inflamatorios.
CA2623239C (en)	2005-09-22	2016-07-12	Medivas, Llc	Solid polymer delivery compositions and methods for use thereof
WO2007035938A2 (en)	2005-09-22	2007-03-29	Medivas, Llc	BIS-(α-AMINO)-DIOL-DIESTER-CONTAINING POLY(ESTER AMIDE) AND POLY(ESTER URETHANE) COMPOSITIONS AND METHODS OF USE
WO2008000534A1 (de) *	2006-06-30	2008-01-03	Gertrud Langhoff	Solubilisatformulierungen
JP6081058B2 (ja) *	2009-03-19	2017-02-15	第一三共株式会社	包装により安定保存された固形製剤
US20110070294A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Administration of Drugs Using Liposomes
US20110070293A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Preparation of Liposomes Comprising Docetaxel
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
IT1404011B1 (it)	2010-12-03	2013-11-08	Uni Degli Studi Magna Graecia Di Catanzaro	Nanovettore coniugato con tsh per il trattamento del cancro della tiroide
PL226015B1 (pl) *	2011-03-03	2017-06-30	Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną	Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
US9873765B2 (en)	2011-06-23	2018-01-23	Dsm Ip Assets, B.V.	Biodegradable polyesteramide copolymers for drug delivery
US9963549B2 (en)	2011-06-23	2018-05-08	Dsm Ip Assets, B.V.	Biodegradable polyesteramide copolymers for drug delivery
FR2979239A1 (fr) *	2011-08-25	2013-03-01	Trophos	Liposome comprenant au moins un derive de cholesterol
EP2682106A1 (en)	2012-07-03	2014-01-08	Phares Pharmaceutical Research N.V.	Method of solubilizing biologically active compounds
WO2014085914A1 (en) *	2012-12-06	2014-06-12	Misudan Enterprises Inc.	Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
WO2016097297A1 (en)	2014-12-18	2016-06-23	Dsm Ip Assets B.V.	Drug delivery system for delivery of acid sensitive drugs
CN110898011B (zh) *	2019-11-27	2022-02-08	西南医科大学	一种依托咪酯纳米制剂及其制备方法
WO2021130170A1 (en) *	2019-12-23	2021-07-01	Zambon S.P.A.	Process for the preparation of dispersions comprising inhalable immunosuppressive active ingredients
JP7608086B2 (ja) *	2020-07-31	2025-01-06	東和薬品株式会社	シームレスカプセル

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3515335C2 (de) *	1985-04-27	1995-01-26	Bayer Ag	Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4117750A1 (de) *	1991-05-30	1992-12-24	Bayer Ag	Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4207481A1 (de) *	1992-03-10	1993-09-16	Bayer Ag	Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung

1994
- 1994-09-12 DE DE4432378A patent/DE4432378A1/de not_active Withdrawn
1995
- 1995-08-28 MY MYPI95002551A patent/MY111841A/en unknown
- 1995-08-30 ES ES95113608T patent/ES2139800T3/es not_active Expired - Lifetime
- 1995-08-30 AT AT95113608T patent/ATE187327T1/de not_active IP Right Cessation
- 1995-08-30 EP EP95113608A patent/EP0700679B1/de not_active Expired - Lifetime
- 1995-08-30 SI SI9530334T patent/SI0700679T1/xx unknown
- 1995-08-30 PT PT95113608T patent/PT700679E/pt unknown
- 1995-08-30 TW TW084109031A patent/TW359616B/zh active
- 1995-08-30 DE DE59507372T patent/DE59507372D1/de not_active Expired - Fee Related
- 1995-08-30 DK DK95113608T patent/DK0700679T3/da active
- 1995-09-05 US US08/523,662 patent/US5653998A/en not_active Expired - Fee Related
- 1995-09-05 AU AU30464/95A patent/AU698441B2/en not_active Ceased
- 1995-09-06 JP JP7252061A patent/JPH0881361A/ja active Pending
- 1995-09-06 NZ NZ272943A patent/NZ272943A/en unknown
- 1995-09-06 UA UA95094063A patent/UA29469C2/uk unknown
- 1995-09-08 PL PL95310344A patent/PL181541B1/pl unknown
- 1995-09-08 IL IL11522295A patent/IL115222A/xx active IP Right Grant
- 1995-09-08 CA CA002157849A patent/CA2157849A1/en not_active Abandoned
- 1995-09-08 FI FI954204A patent/FI954204A7/fi unknown
- 1995-09-11 ZA ZA957604A patent/ZA957604B/xx unknown
- 1995-09-11 RU RU95115542/14A patent/RU2160099C2/ru active
- 1995-09-11 EE EE9500063A patent/EE03377B1/xx not_active IP Right Cessation
- 1995-09-11 SK SK1127-95A patent/SK281611B6/sk unknown
- 1995-09-11 KR KR1019950029487A patent/KR960009998A/ko not_active Abandoned
- 1995-09-11 CZ CZ19952341A patent/CZ287975B6/cs not_active IP Right Cessation
- 1995-09-11 NO NO19953578A patent/NO311556B1/no not_active IP Right Cessation
- 1995-09-12 HU HU9502654A patent/HUT73808A/hu unknown
- 1995-09-12 CN CN95115156A patent/CN1079668C/zh not_active Expired - Fee Related
2000
- 2000-02-14 GR GR20000400362T patent/GR3032664T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ287975B6 (cs)	2001-03-14
MY111841A (en)	2001-01-31
NZ272943A (en)	1996-07-26
KR960009998A (ko)	1996-04-20
FI954204L (fi)	1996-03-13
DE59507372D1 (de)	2000-01-13
TW359616B (en)	1999-06-01
NO953578D0 (no)	1995-09-11
ES2139800T3 (es)	2000-02-16
NO311556B1 (no)	2001-12-10
EP0700679B1 (de)	1999-12-08
PL310344A1 (en)	1996-03-18
EE9500063A (et)	1996-04-15
SI0700679T1 (en)	2000-02-29
EP0700679A1 (de)	1996-03-13
CN1128655A (zh)	1996-08-14
PT700679E (pt)	2000-05-31
SK281611B6 (sk)	2001-05-10
AU698441B2 (en)	1998-10-29
EE03377B1 (et)	2001-04-16
IL115222A (en)	1999-06-20
CA2157849A1 (en)	1996-03-13
ATE187327T1 (de)	1999-12-15
CZ234195A3 (en)	1996-03-13
RU2160099C2 (ru)	2000-12-10
FI954204A0 (fi)	1995-09-08
ZA957604B (en)	1996-04-15
HUT73808A (en)	1996-09-30
AU3046495A (en)	1996-03-28
UA29469C2 (uk)	2000-11-15
IL115222A0 (en)	1995-12-31
DK0700679T3 (da)	2000-05-29
SK112795A3 (en)	1997-02-05
JPH0881361A (ja)	1996-03-26
CN1079668C (zh)	2002-02-27
GR3032664T3 (en)	2000-06-30
FI954204A7 (fi)	1996-03-13
HU9502654D0 (en)	1995-11-28
PL181541B1 (pl)	2001-08-31
US5653998A (en)	1997-08-05
DE4432378A1 (de)	1996-03-14

Publication	Publication Date	Title
DK0700679T3 (da)	2000-05-29	Injicerbare liposomale lægemiddelpræparater
US4956173A (en)	1990-09-11	Composition and use of ademetionine against ageing of the skin
US5057501A (en)	1991-10-15	Methods for treatment of papulosquamous and eczematous diseases
PT742011E (pt)	2002-10-31	Preparacao que pode ser absorvida por via percutanea
ES2088385T3 (es)	1996-08-16	Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
DK0999838T3 (da)	2002-07-08	Selv-emulgerende formulering for lipofile forbindelser
US5219880A (en)	1993-06-15	Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
ES2101574T3 (es)	1997-07-01	Composicion administrable por via oral apta para formar una microemulsion.
DK0830145T3 (da)	2000-10-09	Formuleringer omfattende leflunomid
ES2086802T3 (es)	1996-07-01	Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
NO177774C (no)	1995-11-22	Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel
FI861695A0 (fi)	1986-04-22	Farmaceutiskt preparat och foerfarande foer administrering daerav.
BR9917006A (pt)	2001-10-30	ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico
AU2809697A (en)	1997-11-12	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
KR890701098A (ko)	1989-12-19	히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
TH20333A (th)	1996-09-03	สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้
ES2141049A1 (es)	2000-03-01	Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
TH20138B (th)	2006-07-05	สารที่เตรียมขึ้นสำหรับผิวชั้นนอก

Legal Events

Date	Code	Title	Description
2003-05-05	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN MARCH 2003